Entity Central Index Key
Cover [Abstract]
Document Type
Document Type
Amendment Flag
Amendment Flag
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Trading Symbol
Trading Symbol
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Entity Well-known Seasoned Issuer
Entity Well Known Seasoned Issuer
Entity Voluntary Filers
Entity Voluntary Filers
Entity Current Reporting Status
Entity Current Reporting Status
Entity Interactive Data Current
Entity Interactive Data Current
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Filer Category
Entity Filer Category
Entity Small Business
Entity Small Business
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Ex Transition Period
Entity Ex Transition Period
Entity Shell Company
Entity Shell Company
Entity Public Float
Entity Public Float
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Title of 12(b) Security
Security12b Title
Security Exchange Name
Security Exchange Name
Entity File Number
Entity File Number
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity Tax Identification Number
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, Address Line Two
Entity Address Address Line2
Entity Address, City or Town
Entity Address City Or Town
Entity Address, State or Province
Entity Address State Or Province
Entity Address, Country
Entity Address Country
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Document Annual Report
Document Annual Report
Document Transition Report
Document Transition Report
ICFR Auditor Attestation Flag
Icfr Auditor Attestation Flag
Research and development tax credits receivable.
Statement Of Financial Position [Abstract]
Statement [Table]
Statement [Table]
Class of Stock
Statement Class Of Stock [Axis]
Class of Stock
Class Of Stock [Domain]
Series A Convertible Preferred Shares.
Series A Convertible Preferred Shares
Series A Convertible Preferred Shares [Member]
Series B Convertible Preferred Shares.
Series B Convertible Preferred Shares
Series B Convertible Preferred Shares [Member]
Statement [Line Items]
Statement [Line Items]
ASSETS
Assets [Abstract]
Current assets:
Assets Current [Abstract]
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Marketable securities
Marketable Securities Current
Research and development tax credits receivable
Research And Development Tax Credits Receivable
Other receivables
Other Receivables
Prepaid expenses
Prepaid Expense Current
Total current assets
Assets Current
Property and equipment, net
Property Plant And Equipment Net
Restricted cash
Restricted Cash Noncurrent
Operating lease right-of-use assets
Operating Lease Right Of Use Asset
Other assets
Other Assets Noncurrent
Deferred tax assets
Deferred Income Tax Assets Net
TOTAL ASSETS
Assets
LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Liabilities And Stockholders Equity [Abstract]
Current liabilities:
Liabilities Current [Abstract]
Accounts payable
Accounts Payable Current
Accrued expenses and other current liabilities
Accrued Liabilities And Other Liabilities
Operating lease liabilities, current portion
Operating Lease Liability Current
Deferred revenue, current portion
Contract With Customer Liability Current
Income tax payable
Accrued Income Taxes Current
Total current liabilities
Liabilities Current
Operating lease liabilities, net of current portion
Operating Lease Liability Noncurrent
Deferred revenue, net of current portion
Contract With Customer Liability Noncurrent
TOTAL LIABILITIES
Liabilities
Commitments and Contingencies (note 16)
Commitments And Contingencies
TOTAL CONVERTIBLE PREFERRED SHARES
Temporary Equity Carrying Amount Attributable To Parent
SHAREHOLDERS’ EQUITY (DEFICIT):
Stockholders Equity [Abstract]
Preferred shares, no par value per share; unlimited shares authorized and 0 shares authorized as December 31, 2020 and 2019, respectively; 0 shares issued and outstanding as of December 31, 2020, and 2019, respectively
Preferred Stock Value
Common shares, no par value per share; unlimited shares authorized as of December 31, 2020 and 2019; 36,902,924 and 1,528,374 shares issued and outstanding as of December 31, 2020 and 2019, respectively
Common Stock Value
Additional paid-in capital
Additional Paid In Capital Common Stock
Accumulated deficit
Retained Earnings Accumulated Deficit
TOTAL SHAREHOLDERS’ EQUITY (DEFICIT)
Stockholders Equity
TOTAL LIABILITIES, CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Liabilities And Stockholders Equity
Preferred stock authorized unlimited.
Temporary equity shares authorized unlimited.
Temporary equity par value
Temporary Equity Par Or Stated Value Per Share
Temporary equity shares authorized
Temporary Equity Shares Authorized
Temporary equity shares authorized
Temporary Equity Shares Authorized Unlimited
Temporary equity shares issued
Temporary Equity Shares Issued
Temporary equity shares outstanding
Temporary Equity Shares Outstanding
Temporary equity, liquidation and redemption value
Temporary Equity Liquidation Preference
Common stock par value
Common Stock No Par Value
Common stock shares authorized
Common Stock Shares Authorized Unlimited
Common stock shares issued
Common Stock Shares Issued
Common stock shares outstanding
Common Stock Shares Outstanding
Preferred stock par value
Preferred Stock No Par Value
Preferred stock shares authorized
Preferred Stock Authorized Unlimited
Preferred stock shares authorized
Preferred Stock Shares Authorized
Preferred stock shares issued
Preferred Stock Shares Issued
Preferred stock shares outstanding
Preferred Stock Shares Outstanding
Revenue from collaboration agreements.
Change in fair value of preferred share tranche obligation.
Net income loss and comprehensive income loss.
Income Statement [Abstract]
Revenue:
Revenues [Abstract]
Collaboration agreements
Revenue From Collaboration Agreements
Operating expenses:
Operating Expenses [Abstract]
Research and development, net of tax credits
Research And Development Expense
General and administrative
General And Administrative Expense
Total operating expenses
Operating Expenses
Loss from operations
Operating Income Loss
Other (expense) income, net
Nonoperating Income Expense [Abstract]
Realized and unrealized (loss) gain on foreign exchange
Foreign Currency Transaction Gain Loss Before Tax
Change in fair value of Series A Preferred Share tranche obligation
Change In Fair Value Of Preferred Share Tranche Obligation
Interest income
Investment Income Interest
Other expense
Other Nonoperating Expense
Total other expense, net
Nonoperating Income Expense
Loss before income taxes
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Income tax benefit (expense)
Income Tax Expense Benefit
Net loss and comprehensive loss
Net Income Loss And Comprehensive Income Loss
Net loss attributable to common shareholders—basic and diluted
Net Income Loss Available To Common Stockholders Basic
Net loss per share attributable to common shareholders—basic and diluted
Earnings Per Share Basic And Diluted
Weighted-average common shares outstanding—basic and diluted
Weighted Average Number Of Share Outstanding Basic And Diluted
Temporary equity stock issued during period shares new issues.
Temporary equity adjustments to additional paid in capital termination.
Issuance of warrants and conversion into common stock during period, value.
Issuance of warrants and conversion into common stock during period, shares
Statement Of Stockholders Equity [Abstract]
Additional Paid-in Capital
Statement Equity Components [Axis]
Equity Component
Equity Component [Domain]
Common Shares
Common Stock [Member]
Additional Paid-in Capital
Additional Paid In Capital [Member]
Accumulated Deficit
Retained Earnings [Member]
Sale of Stock
Subsidiary Sale Of Stock [Axis]
Sale of Stock
Sale Of Stock Name Of Transaction [Domain]
Initial Public Offering
I P O [Member]
Balance
Temporary equity balance, Shares
Temporary equity balance, Value
Balance, Shares
Shares Outstanding
Issuance of convertible preferred shares, net of issuance costs
Temporary Equity Stock Issued During Period Value New Issues
Issuance of convertible preferred shares, net of issuance costs, Shares
Temporary Equity Stock Issued During Period Shares New Issues
Series A Tranche 3 termination
Temporary Equity Adjustments To Additional Paid In Capital Termination
Exercise of vested stock options
Stock Issued During Period Value Stock Options Exercised
Exercise of common stock options, Shares
Stock Issued During Period Shares Stock Options Exercised
Share-based compensation expense
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Issuance of common shares upon initial public offering, net of issuance costs
Stock Issued During Period Value New Issues
Issuance of common shares upon initial public offering, net of issuance costs , Shares
Stock Issued During Period Shares New Issues
Conversion of convertible preferred shares into an equivalent number of common shares, Value
Stock Issued During Period Value Conversion Of Convertible Securities
Conversion of convertible preferred shares into an equivalent number of common shares, Shares
Stock Issued During Period Shares Conversion Of Convertible Securities
Issuance of warrant and conversion into common shares,Value
Issuance Of Warrants And Conversion Into Common Stock During Period Value
Issuance of warrant and conversion into common shares, Shares
Issuance Of Warrants And Conversion Into Common Stock During Period Shares
Net loss and comprehensive loss
Balance
Temporary equity balance, Shares
Temporary equity balance, Value
Balance, Shares
Stock issuance costs
Payments Of Stock Issuance Costs
Change in fair value of preferred stock tranche obligation.
Foreign currency transaction gain (loss).
increase decrease in research and development tax credits receivable.
Increase decrease in accrued expenses and other current liabilities.
Increase decrease in operating lease liability current.
Increase decrease in operating lease liability net.
Statement Of Cash Flows [Abstract]
Series A Preferred Shares
Series A Preferred Stock [Member]
Series B Preferred Shares
Series B Preferred Stock [Member]
Cash Flows From Operating Activities:
Net Cash Provided By Used In Operating Activities [Abstract]
Net loss and comprehensive loss for the year
Profit Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Share-based compensation expense
Share Based Compensation
Depreciation expense
Depreciation
Change in fair value of Series A Preferred Shares tranche obligation
Change In Fair Value Of Preferred Stock Tranche Obligation
Non-cash lease expense
Provision For Loan And Lease Losses
Foreign exchange (gain) loss
Foreign Currency Transaction Gain Loss
Deferred tax asset
Increase Decrease In Deferred Income Taxes
Changes in operating assets and liabilities:
Increase Decrease In Operating Capital [Abstract]
Prepaid expenses and other current assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Research and development tax credits receivable
Increase Decrease In Research And Development Tax Credits Receivable
Other receivables
Increase Decrease In Other Receivables
Other non-current assets
Increase Decrease In Other Operating Assets
Accounts payable
Increase Decrease In Accounts Payable
Accrued expenses and other current liabilities
Increase Decrease In Accrued Expenses And Other Current Liabilities
Operating lease liabilities, current portion
Increase Decrease In Operating Lease Liability Current
Income tax payable
Increase Decrease In Income Taxes
Operating lease liabilities, net of current portion
Increase Decrease In Operating Lease Liability Net
Deferred revenue
Increase Decrease In Deferred Revenue
Net cash used in operating activities
Net Cash Provided By Used In Operating Activities
Cash Flows From Investing Activities:
Net Cash Provided By Used In Investing Activities [Abstract]
Purchase of property and equipment
Payments To Acquire Property Plant And Equipment
Purchase of marketable securities
Payments To Acquire Marketable Securities
Net cash used in investing activities
Net Cash Provided By Used In Investing Activities
Cash Flows From Financing Activities:
Net Cash Provided By Used In Financing Activities [Abstract]
Proceeds from issuance of preferred shares, net
Proceeds From Issuance Of Preferred Stock And Preference Stock
Proceeds from exercise of stock options
Proceeds From Stock Options Exercised
Proceeds from issuance of warrant
Proceeds From Issuance Of Warrants
Net proceeds from issuance of common shares in initial public offering
Proceeds From Issuance Initial Public Offering
Net cash provided by financing activities
Net Cash Provided By Used In Financing Activities
Effect of exchange rate fluctuations on cash held
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
Net Increase In Cash And Cash Equivalents And Restricted Cash
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
Cash and cash equivalents and restricted cash at beginning of year
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
Cash and cash equivalents and restricted cash at end of year
Reconciliation Of Cash And Cash Equivalents And Restricted Cash
Restricted Cash And Cash Equivalents [Abstract]
Cash and cash equivalents
Cash Equivalents At Carrying Value
Restricted cash
Restricted Cash
Total cash and cash equivalents and restricted cash
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
Supplemental Disclosure Of Cash Flow Information:
Supplemental Cash Flow Information [Abstract]
Cash interest received
Interest Paid Net
Cash taxes paid
Income Taxes Paid
Property and equipment purchases incurred but not yet paid
Capital Expenditures Incurred But Not Yet Paid
Right-of-use assets obtained in exchange for new operating lease liability
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
Conversion of Series A and B Preferred Shares into common shares
Conversion Of Stock Amount Converted1
Conversion of warrant into common shares
Documents Incorporated by Reference
Documents Incorporated By Reference [Text Block]
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Organization and Nature of Business
Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Fair Value Disclosures [Abstract]
Fair Value Measurements
Fair Value Disclosures [Text Block]
Investments Debt And Equity Securities [Abstract]
Cash and Cash Equivalents and Marketable Securities
Cash Cash Equivalents And Marketable Securities [Text Block]
Property Plant And Equipment [Abstract]
Property and Equipment, Net
Property Plant And Equipment Disclosure [Text Block]
Payables And Accruals [Abstract]
Accrued Expenses and Other Current Liabilities
Accounts Payable Accrued Liabilities And Other Liabilities Disclosure Current [Text Block]
License agreements.
License agreements.
License Agreements [Abstract]
License Agreements
License Agreements Disclosure [Text Block]
Leases [Abstract]
Leases
Lessee Operating Leases [Text Block]
Convertible preferred shares disclosure.
Equity [Abstract]
Convertible Preferred Shares
Convertible Preferred Shares Disclosure [Text Block]
Shareholders’ Equity (Deficit)
Stockholders Equity Note Disclosure [Text Block]
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Stock-Based Compensation
Disclosure Of Compensation Related Costs Share Based Payments [Text Block]
Collaboration
Collaborative Arrangement Disclosure [Text Block]
Income Tax Disclosure [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Earnings Per Share [Abstract]
Net Loss per Share
Earnings Per Share [Text Block]
Research And Development [Abstract]
Government Assistance
Research Development And Computer Software Disclosure [Text Block]
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies
Commitments And Contingencies Disclosure [Text Block]
Foreign currency risk.
Foreign Currency Risk [Abstract]
Currency Risk
Foreign Currency Disclosure [Text Block]
Related Party Transactions [Abstract]
Related Parties
Related Party Transactions Disclosure [Text Block]
Segment Reporting [Abstract]
Geographic Information
Segment Reporting Disclosure [Text Block]
Subsequent Events [Abstract]
Subsequent Events
Subsequent Events [Text Block]
Basis of Presentation
Basis Of Accounting Policy Policy [Text Block]
Principles of Consolidation
Consolidation Policy [Text Block]
Foreign Currencies
Foreign Currency Transactions And Translations Policy [Text Block]
Segment Information
Segment Reporting Policy Policy [Text Block]
Use of Estimates
Use Of Estimates
COVID19 pandemic.
COVID-19 Pandemic
C O V I D19 Pandemic Policy [Text Block]
Cash and Cash Equivalents
Cash And Cash Equivalents Policy [Text Block]
Marketable Securities
Marketable Securities Policy
Restricted Cash.
Restricted Cash
Restricted Cash Policy [Text Block]
Concentrations of Credit Risk and Off-Balance Sheet Risk
Concentration Risk Credit Risk
Comprehensive Loss
Comprehensive Income Policy Policy [Text Block]
Fair Value Measurements
Fair Value Measurement Policy Policy [Text Block]
Property and Equipment, Net
Property Plant And Equipment Policy [Text Block]
Impairment of Long-Lived Assets
Impairment Or Disposal Of Long Lived Assets Policy [Text Block]
Leases
Lessee Leases Policy [Text Block]
Revenue Recognition
Revenue Recognition Policy [Text Block]
Research and Development Expenses
Research And Development Expense Policy
Accrued research and development expenses.
Accrued Research and Development Expenses
Accrued Research And Development Expenses Policy [Text Block]
Share-Based compensation
Share Based Compensation Option And Incentive Plans Policy
Convertible preferred shares.
Classification of Convertible Preferred Shares
Convertible Preferred Shares Policy [Text Block]
Share issuance costs.
Share Issuance Costs
Share Issuance Costs Policy [Text Block]
Net Loss per Share
Earnings Per Share Policy [Text Block]
Income Taxes
Income Tax Policy [Text Block]
Research and development tax credits.
Research and Development Tax Credits
Research And Development Tax Credits Policy [Text Block]
Emerging growth company status.
Emerging Growth Company Status
Emerging Growth Company Status Policy [Text Block]
Recently Adopted Accounting Pronouncements
New Accounting Pronouncements Policy Policy [Text Block]
Recently issued accounting pronouncements.
Recently Issued Accounting Pronouncements
Recently Issued Accounting Pronouncements Policy [Text Block]
Schedule of estimated useful lives of property and equipment.
Schedule of Estimated Useful Lives of Property and Equipment
Schedule Of Estimated Useful Lives Of Property And Equipment Table [Text Block]
Schedule of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]
Schedule of Aggregate Fair Value of Series A Preferred Share Tranche Obligation using Level 3 Inputs
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block]
Summary of Cash and Cash Equivalents and Marketable Securities
Schedule Of Available For Sale Securities Reconciliation Table [Text Block]
Schedule of Property and Equipment, Net
Property Plant And Equipment [Text Block]
Schedule of accrued expenses and other current liabilities.
Schedule of Accrued Expenses and Other Current Liabilities
Schedule Of Accrued Expenses And Other Current Liabilities Table [Text Block]
Summary of Lease Costs
Lease Cost Table [Text Block]
Summary of other operating lease information.
Summary of Other Operating Lease Information
Summary Of Other Operating Lease Information Table [Text Block]
Summary of Future Minimum Lease Payments under Operating Leases
Lessee Operating Lease Liability Maturity Table [Text Block]
Summary of Preferred Shares
Schedule Of Stock By Class [Text Block]
Schedule of Fair Value of Stock Options Determined on Grant Date Using Black Scholes Option-Pricing Model
Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]
Schedule of Stock Option Activity
Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]
Schedule of Share-based Compensation Expense
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]
Schedule of Transaction Price Performance Obligations
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions Table [Text Block]
Summary of Loss Before Provision for Income Taxes
Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]
Summary of Reconciliation of Provision for Income Taxes
Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]
Summary of recognized tax benefit of losses expire.
Summary of Losses Expire
Summary Of Recognized Tax Benefit Of Losses Expire Table [Text Block]
Summary of investment tax credits expire.
Summary of Investment Tax Credits Expire
Summary Of Investment Tax Credits Expire Table [Text Block]
Summary of Deferred Tax Assets
Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]
Summary of Computation of Basic and Diluted Net Loss Per Share Attributable To Common Shareholders
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Computation of Diluted Net Loss Per Share in Attributable to Common Shareholders Indicate to Anti Diluted Effect
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Schedule of Commitments to Settle Contractual Obligations
Contractual Obligation Fiscal Year Maturity Schedule Table [Text Block]
Schedule of financial position exposure.
Schedule of Financial Position Exposure
Schedule Of Financial Position Exposure Table [Text Block]
Schedule of Property and Equipment, Net and Right-of-Use Assets by Location
Long Lived Assets By Geographic Areas Table [Text Block]
Organization and nature of business.
Organization and nature of business.
Organization And Nature Of Business [Table]
Organization And Nature Of Business [Table]
Exercise of Underwriters Option
Over Allotment Option [Member]
Organization and Nature of Business [Line Items]
Organization And Nature Of Business [Line Items]
Entity incorporation, date of incorporation
Entity Incorporation Date Of Incorporation
Reverse stock split of share capital
Stockholders Equity Reverse Stock Split
Conversion ratio
Stockholders Equity Note Stock Split Conversion Ratio1
Gross proceeds from initial public offering.
Shares issued
Gross proceeds from IPO
Gross Proceeds From Initial Public Offering
Net proceeds from IPO
Convertible preferred shares converted into common shares
Conversion Of Stock Shares Converted1
Shares issued upon exercise of warrants outstanding
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
Restricted cash
Significant off-balance sheet risk, description
Concentration Risk Credit Risk Financial Instruments Off Balance Sheet Risk
Schedule Of Property Plant And Equipment [Table]
Schedule Of Property Plant And Equipment [Table]
Long-Lived Tangible Asset
Property Plant And Equipment By Type [Axis]
Long-Lived Tangible Asset
Property Plant And Equipment Type [Domain]
Computer Equipment
Computer Equipment [Member]
Office Equipment
Office Equipment [Member]
Laboratory Equipment
Equipment [Member]
Leasehold Improvements
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property Plant And Equipment [Line Items]
Estimated useful lives of assets
Property Plant And Equipment Useful Life
Estimated useful lives of assets, description
Property Plant And Equipment Estimated Useful Lives
Impairment of long-lived assets
Impairment Of Long Lived Assets To Be Disposed Of
Share based compensation, expected dividend yield assumed
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Measurement Frequency
Fair Value By Measurement Frequency [Axis]
Measurement Frequency
Fair Value Measurement Frequency [Domain]
Fair Value Measurements, Recurring
Fair Value Measurements Recurring [Member]
Asset Class
Fair Value By Asset Class [Axis]
Asset Class
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]
Money Market Funds
Money Market Funds [Member]
Fair Value Hierarchy and NAV
Fair Value By Fair Value Hierarchy Level [Axis]
Fair Value Hierarchy and NAV
Fair Value Measurements Fair Value Hierarchy [Domain]
Quoted Prices in Active Markets for identical Assets (Level 1)
Fair Value Inputs Level1 [Member]
Significant Other Observable Inputs (Level 2)
Fair Value Inputs Level2 [Member]
Significant Other Observable Inputs (Level 3)
Fair Value Inputs Level3 [Member]
Investment Type
Investment Type [Axis]
Investments
Investment Type Categorization [Member]
U.S. Treasury Notes
U S Treasury Notes Securities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets
Assets Fair Value Disclosure [Abstract]
Total financial assets
Assets Fair Value Disclosure
Fair value, assets, transfers between all levels.
Fair value, assets, transfers between levels
Fair Value Assets Transfers Between All Levels
Financial assets
Financial liabilities
Financial Liabilities Fair Value Disclosure
Change in fair value of Series A Preferred Shares tranche obligation recorded in other expense
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
Fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, termination.
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Liability Class
Fair Value By Liability Class [Axis]
Fair Value by Liability Class
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]
Series A preferred share tranche obligation.
Series A Preferred Share Tranche Obligation
Series A Preferred Share Tranche Obligation [Member]
Level 3 Inputs
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
Change in fair value
Tranche 2 settlement of obligation
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
Tranche 3 termination
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Termination
Ending balance
Debt Securities Available For Sale [Table]
Debt Securities Available For Sale [Table]
Cash and Cash Equivalents
Cash And Cash Equivalents [Axis]
Cash and Cash Equivalents
Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]
Schedule Of Available For Sale Securities [Line Items]
Schedule Of Available For Sale Securities [Line Items]
Amortized Cost
Available For Sale Debt Securities Amortized Cost Basis
Unrealized Gains
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
Unrealized Losses
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
Fair Value
Available For Sale Securities Debt Securities
Unrealized gains
Unrealized losses
Money market funds
Money Market Funds At Carrying Value
Marketable securities
Marketable Securities
Property Plant And Equipment Net [Abstract]
Leasehold Improvements
Leaseholds And Leasehold Improvements [Member]
Property and equipment, gross
Property Plant And Equipment Gross
Less: Accumulated depreciation
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Property and equipment, net
Income Statement Location
Income Statement Location [Axis]
Income Statement Location
Income Statement Location [Domain]
Research and Development Expense
Research And Development Expense [Member]
General and Administrative Expense
General And Administrative Expense [Member]
Accrued research and development expense current.
Accrued expenses and other liabilities current
Accrued compensation and benefits
Employee Related Liabilities Current
Accrued research and development expense
Accrued Research And Development Expense Current
Accrued professional services
Accrued Professional Fees Current
Other
Other Liabilities Current
Total accrued expenses and other current liabilities
Accrued Expenses And Other Liabilities Current
License agreement milestone and royalty payments upon achievement of certain clinical and commercial milestones.
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Collaborative Arrangement and Arrangement Other than Collaborative
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Arrangements And Nonarrangement Transactions [Member]
New York university agreement.
NYU Agreement
New York University Agreement [Member]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
License agreement milestone and royalty payments upon achievement of certain clinical and commercial milestones
License Agreement Milestone And Royalty Payments Upon Achievement Of Certain Clinical And Commercial Milestones
Accrual potential milestone and royalty payments.
Accrual of potential future milestone or royalty payment
Accrual Potential Milestone And Royalty Payments
Number of operating leases.
Lessee Lease Description [Table]
Lessee Lease Description [Table]
Credit Facility
Credit Facility [Axis]
Credit Facility
Credit Facility [Domain]
Standby Letters of Credit
Standby Letters Of Credit [Member]
Office and laboratory space.
Office and Laboratory Space
Office And Laboratory Space [Member]
Geographical
Statement Geographical [Axis]
Geographical
Segment Geographical [Domain]
Montreal, Quebec
QUEBEC
Cambridge, Massachusetts
MASSACHUSETTS
Lessee Lease Description [Line Items]
Lessee Lease Description [Line Items]
Number of operating leases
Number Of Operating Leases
Lessee, operating lease, existence of option to terminate
Lessee Operating Lease Existence Of Option To Terminate
Lessee operating lease expiration month and year.
Operating lease, term of contract
Lessee Operating Lease Term Of Contract
Operating lease, expiration month and year
Lessee Operating Lease Expiration Month And Year
Line of credit facility, unused amount
Line Of Credit Facility Commitment Fee Amount
Operating lease, existence of option to extend
Lessee Operating Lease Existence Of Option To Extend
Operating lease, option to extend, description
Lessee Operating Lease Option To Extend
Prepaid rent
Prepaid Rent
Operating Lease, renewal term
Lessee Operating Lease Renewal Term
Lease Cost
Lease Cost [Abstract]
Operating lease cost
Operating Lease Cost
Short-term lease cost
Short Term Lease Cost
Variable lease cost
Variable Lease Cost
Total lease cost
Lease Cost
Operating cash flows for operating leases
Operating Lease Payments
Weighted-average remaining lease term
Operating Lease Weighted Average Remaining Lease Term1
Weighted-average discount rate
Operating Lease Weighted Average Discount Rate Percent
Implicit interest rate.
Implicit interest rate
Implicit Interest Rate
2021
Lessee Operating Lease Liability Payments Due Next Twelve Months
2022
Lessee Operating Lease Liability Payments Due Year Two
2023
Lessee Operating Lease Liability Payments Due Year Three
2024
Lessee Operating Lease Liability Payments Due Year Four
2025
Lessee Operating Lease Liability Payments Due Year Five
Total lease payments
Lessee Operating Lease Liability Payments Due
Less: interest
Lessee Operating Lease Liability Undiscounted Excess Amount
Total lease liabilities
Operating Lease Liability
Number of tranches.
Temporary Equity By Class Of Stock [Table]
Temporary Equity By Class Of Stock [Table]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Maximum
Maximum [Member]
Minimum
Minimum [Member]
Debt Instrument
Debt Instrument [Axis]
Debt Instrument, Name
Debt Instrument Name [Domain]
First tranche.
First Tranche
First Tranche [Member]
Second tranche.
Second Tranche
Second Tranche [Member]
Temporary Equity [Line Items]
Temporary Equity [Line Items]
Number of tranches
Number Of Tranches
Proceeds from Issuance of convertible preferred stock
Proceeds From Issuance Of Convertible Preferred Stock
Beneficial conversion feature
Debt Instrument Convertible Beneficial Conversion Feature
Convertible preferred shares converted into common shares
Carrying Value
Common Shares Issuable Upon Conversion
Convertible Preferred Stock Shares Issued Upon Conversion
Preferred stock noncumulative dividend rate percentage.
Preferred shares, noncumulative dividends
Preferred Stock Noncumulative Dividend Rate Percentage
Preferred stock, conversion basis
Preferred Stock Conversion Basis
Temporary equity, terms of conversion, trigger, minimum price per share in initial public offering.
Temporary equity, terms of conversion, trigger, minimum gross proceeds from initial public offering.
Percentage of holders of preferred shares election to convert preferred shares.
Threshold price per share in initial public offering that triggers automatic conversion of preferred convertible shares into common shares
Temporary Equity Terms Of Conversion Trigger Minimum Price Per Share In Initial Public Offering
Threshold gross proceeds of initial public offering that triggers automatic conversion of preferred convertible shares into common shares
Temporary Equity Terms Of Conversion Trigger Minimum Gross Proceeds From Initial Public Offering
Percentage of holder of preferred shares election to convert the preferred shares
Percentage Of Holders Of Preferred Shares Election To Convert Preferred Shares
Percentage of liquidation rights waived by holder of preferred shares.
Percentage of liquidation rights waived by holder of preferred shares
Percentage Of Liquidation Rights Waived By Holder Of Preferred Shares
Schedule Of Stock By Class [Table]
Schedule Of Stock By Class [Table]
Legal Entity
Legal Entity [Axis]
Entity
Entity [Domain]
Affiliate of Bristol Myers Squibb Company.
Affiliate of Bristol Myers Squibb
Affiliate Of Bristol Myers Squibb Company [Member]
Plan Name
Plan Name [Axis]
Plan Name
Plan Name [Domain]
Two thousand twenty employee share purchase plan.
2020 Employee Share Purchase Plan
Two Thousand Twenty Employee Share Purchase Plan [Member]
Class Of Stock [Line Items]
Class Of Stock [Line Items]
Warrant exercise price per share
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
Shares issued, price per share
Shares Issued Price Per Share
Annual increase in number of shares available for issuance as percentage on outstanding shares of common stock on final day of preceding calendar year.
Annual increase in number of shares available for issuance maximum number of common stock issued.
Shares of common stock reserved for future issuance
Common Stock Capital Shares Reserved For Future Issuance
Annual increase in number of shares available for issuance as percentage of outstanding shares common stock on final day of preceding calendar year
Annual Increase In Number Of Shares Available For Issuance As Percentage On Outstanding Shares Of Common Stock On Final Day Of Preceding Calendar Year
Annual increase in number of shares available for issuance maximum number of common stock issued
Annual Increase In Number Of Shares Available For Issuance Maximum Number Of Common Stock Issued
Purchase price of shares as percentage of fair market value of common stock on date of purchase.
Purchase price of shares as percentage of fair market value of common stock on date of purchase
Purchase Price Of Shares As Percentage Of Fair Market Value Of Common Stock On Date Of Purchase
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Repare Therapeutics Incorporation option plan.
Option Plan
Repare Therapeutics Incorporation Option Plan [Member]
Two thousand twenty equity incentive plan.
2020 Equity Incentive Plan
Two Thousand Twenty Equity Incentive Plan [Member]
Subsequent Event Type
Subsequent Event Type [Axis]
Subsequent Event Type
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Event [Member]
Vesting
Vesting [Axis]
Vesting
Vesting [Domain]
Vesting on First Anniversary Date of Grant
Share Based Compensation Award Tranche One [Member]
Vesting on Monthly Basis at Rate of 1/36th
Share Based Compensation Award Tranche Two [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares authorized to be issued
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
Common stock capital shares initially reserved for future issuance.
Shares of common stock initially reserved for future issuance
Common Stock Capital Shares Initially Reserved For Future Issuance
Exercise price per share as minimum percentage of fair value of common share.
Exercise price per share as minimum percentage of fair value of common share
Exercise Price Per Share As Minimum Percentage Of Fair Value Of Common Share
Share based compensation arrangement by share based payment monthly vesting rate
Expiration period
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
Vesting percentage
Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
Monthly vesting rate
Share Based Compensation Arrangement By Share Based Payment Monthly Vesting Rate
Risk-free interest rate
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
Expected term (in years)
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
Expected volatility
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
Expected dividend yield
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
Fair value of stock options granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
Number of shares, Outstanding at beginning of period
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Number of shares, Granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
Number of shares, Exercised
Number of shares, Forfeited
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
Number of shares, Outstanding at end of period
Number of shares, Options Exercisable
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
Number of shares, Options Unvested
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
Weighted average exercise price, Outstanding at beginning of period
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
Weighted average exercise price, Granted
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
Weighted average exercise price, Exercised
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
Weighted average exercise price, Forfeited
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
Weighted average exercise price, Outstanding at end of period
Weighted average exercise price, Options exercisable
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
Weighted average exercise price, Options Unvested
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
Weighted average remaining contractual term (in years) , Outstanding
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
Weighted average remaining contractual term (in years), Options Exercisable
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
Weighted average remaining contractual term (in years), Options Unvested
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
Intrinsic value, Outstanding at beginning of period
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
Intrinsic value, Outstanding at end of period
Intrinsic value, Options exercisable
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
Intrinsic value, Options unvested
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
Intrinsic value of options exercised
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
Fair value of vested options
Fair value of options vested
Fair Value Of Vested Options
Additional paid in capital share-based payment arrangement exercised options credited to common shares.
Number of options exercised
Exercised options, weighted-average exercise price
Aggregate proceeds from exercise of options
Decrease in additional paid-in capital as exercised options credited to common shares
Additional Paid In Capital Share Based Payment Arrangement Exercised Options Credited To Common Shares
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]
Award Type
Award Type [Axis]
Award Type
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Stock Options
Employee Stock Option [Member]
Research and Development
General and Administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Total share-based compensation expense
Allocated Share Based Compensation Expense
Unrecognized share-based compensation expense related to unvested stock options
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
Unrecognized share-based compensation expense related to unvested stock options, weighted average period
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
Product and Service
Product Or Service [Axis]
Product and Service
Products And Services [Domain]
Research development and regulatory milestones.
Research, Development and Regulatory Milestones
Research Development And Regulatory Milestones [Member]
Commercial milestones.
Commercial Milestones
Commercial Milestones [Member]
Collaboration and license agreement.
Collaboration and License Agreement
Collaboration And License Agreement [Member]
Bristol-Myers Squibb Company.
Bristol-Myers Squibb Company
Bristol Myers Squibb Company [Member]
Non-refundable upfront payment received
Contract With Customer Liability
Initial nonrefundable upfront fee payment received
Proceeds From Collaborators
Deferred revenue, additions
Deferred Revenue Additions
Milestone payments entitled to be received
Revenue Remaining Performance Obligation
Collaboration term expiration period.
Collaboration term expiration period
Collaboration Term Expiration Period
Research activities.
Research Activities
Research Activities [Member]
Options to license druggable targets.
Options to License Druggable Targets
Options To License Druggable Targets [Member]
Options to license undruggable target.
Options to License Undruggable Targets
Options To License Undruggable Target [Member]
Transaction price
Deferred revenue recognized
Deferred Revenue Revenue Recognized1
Deferred revenue
Deferred Revenue
Deferred revenue, current
Deferred Revenue Current
Deferred revenue, noncurrent
Deferred Revenue Noncurrent
Canada
Income Loss From Continuing Operations Before Income Taxes Domestic
Foreign
Income Loss From Continuing Operations Before Income Taxes Foreign
Loss before the provision for income taxes
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
Income tax rate reconciliation, nondeductible expense, accounting charges.
Loss before income taxes
Income tax at statutory rate
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
Computed income tax recovery
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
Federal investment tax credit
Income Tax Reconciliation Tax Credits
Accounting charges not deductible for tax purposes
Income Tax Rate Reconciliation Nondeductible Expense Accounting Charges
Other
Income Tax Reconciliation Other Adjustments
Change in valuation allowance
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
Tax (benefit) expense
Income tax losses.
Income taxes.
Income taxes.
Income Taxes [Table]
Income Taxes [Table]
Income Tax Authority
Income Tax Authority [Axis]
Income Tax Authority
Income Tax Authority [Domain]
U.S. Federal Research and Development
Domestic Country [Member]
U.S. State Research and Development
State And Local Jurisdiction [Member]
Income Taxes [Line Items]
Income Taxes [Line Items]
Income tax losses
Income Tax Losses
Income tax losses expire one.
Income tax losses expire two.
Income tax losses expire three.
Income tax losses expire four.
Income tax losses expire five.
2040
Income Tax Losses Expire One
2039
Income Tax Losses Expire Two
2038
Income Tax Losses Expire Three
2037
Income Tax Losses Expire Four
2036
Income Tax Losses Expire Five
Total
Scientific Research and experimental development expenditures.
Scientific research and experimental development expenditures
Scientific Research And Experimental Development Expenditures
Investment tax credits.
Investment tax credits
Investment Tax Credits
Investment tax credits expire one.
Investment tax credits expire two.
Investment tax credits expire three.
Investment tax credits expire four.
Investment tax credits expire five.
2040
Investment Tax Credits Expire One
2039
Investment Tax Credits Expire Two
2038
Investment Tax Credits Expire Three
2037
Investment Tax Credits Expire Four
2036
Investment Tax Credits Expire Five
Total
Tax credit carry forward expiration year.
Tax credit carryforward, amount
Tax Credit Carryforward Amount
Tax credit carry forward expiration year
Tax Credit Carry Forward Expiration Year
Deferred tax assets net federal investment tax credits.
Deferred tax assets operating lease right-of-use assets.
Deferred tax liabilities operating lease liability.
Deferred tax liabilities accrued expense and other liabilities.
Deferred tax assets share based compensation cost.
Net operating loss carryforwards
Deferred Tax Assets Operating Loss Carryforwards
Net research and development expenditures
Deferred Tax Assets In Process Research And Development
Share issuance costs
Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
Net federal investment tax credits
Deferred Tax Assets Net Federal Investment Tax Credits
U.S. research and development tax credits
Deferred Tax Assets Tax Credit Carryforwards Research
Tax basis of property and equipment in excess of carrying values
Deferred Tax Assets Property Plant And Equipment
Operating lease right-of-use assets
Deferred Tax Assets Operating Lease Right Of Use Assets
Operating lease liability
Deferred Tax Liabilities Operating Lease Liability
Accrued expense and other liabilities
Deferred Tax Liabilities Accrued Expense And Other Liabilities
Deferred revenue
Deferred Tax Assets Deferred Income
Share-based compensation
Deferred Tax Assets Share Based Compensation Cost
Total deferred tax assets
Deferred Tax Assets Gross
Valuation allowance
Deferred Tax Assets Valuation Allowance
Net deferred tax assets
Deferred Tax Assets Liabilities Net
Tax examination
Income Tax Examination Year Under Examination
Unrecognized tax positions
Unrecognized Tax Benefits
Accrued interest or penalties
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
Net income loss attributable to common shareholders basic and diluted.
Earnings Per Share Basic And Diluted [Abstract]
Numerator:
Net Income Loss Available To Common Stockholders Basic [Abstract]
Net loss attributable to common shareholders—basic and diluted
Net Income Loss Attributable To Common Stockholders Basic And Diluted
Denominator:
Weighted Average Number Of Shares Outstanding [Abstract]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Options to purchase common shares.
Options to Purchase Common Shares
Options To Purchase Common Shares [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share amount
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Reduction of research and development expenditures
2021
Contractual Obligation Due In Next Twelve Months
2022
Contractual Obligation Due In Second Year
2023
Contractual Obligation Due In Third Year
2024
Contractual Obligation Due In Fourth Year
2025
Contractual Obligation Due In Fifth Year
Total
Contractual Obligation
Contractual obligation period.
Contractual Obligation Paid.
Commitments and contingencies disclosure.
Commitments and contingencies disclosure.
Commitments And Contingencies Disclosure [Table]
Commitments And Contingencies Disclosure [Table]
The University of Texas M. D. Anderson Cancer Center.
MDACC
The University Of Texas M D Anderson Cancer Center [Member]
Research and Development Arrangement, Contract to Perform for Others, Type
Research And Development Arrangement Contract To Perform For Others By Type [Axis]
Research and Development Arrangement, Contract to Perform for Others, Type
Research And Development Arrangement Contract To Perform For Others Type [Domain]
Preclinical studies and clinical trials.
Preclinical Studies and Clinical Trials
Preclinical Studies And Clinical Trials [Member]
Broad institute, inc.
Broad Institute, Inc.
Broad Institute Inc [Member]
Specialty screening services.
Specialty Screening Services
Specialty Screening Services [Member]
Maximum
Category of Item Purchased
Long Term Purchase Commitment By Category Of Item Purchased [Axis]
Long-term Purchase Commitment, Category of Item Purchased
Long Term Purchase Commitment Category Of Item Purchased [Domain]
Research and Development Service Agreement
Research And Development Arrangement [Member]
Commitments And Contingencies Disclosure [Line Items]
Commitments And Contingencies Disclosure [Line Items]
Contractual obligation
Contractually Specified Servicing Fees Amount
Contractual obligation period
Contractual Obligation Period
Contractual obligation paid
Contractual Obligation Paid
Contractual obligation amount per year.
Contractual obligation per year
Contractual Obligation Amount Per Year
Potential milestone payments achieved.
Termination payments.
Potential milestone payments achieved
Potential Milestone Payments Achieved
Termination payments
Termination Payments
Foreign currency risk.
Foreign currency risk.
Foreign Currency Risk [Table]
Foreign Currency Risk [Table]
Balance Sheet Location
Balance Sheet Location [Axis]
Balance Sheet Location
Balance Sheet Location [Domain]
Cash
Cash [Member]
Restricted cash.
Restricted Cash
Restricted Cash [Member]
Research and development tax credits receivable.
Research and Development Tax Credits Receivable
Research And Development Tax Credits Receivable [Member]
Other receivables.
Other Receivables
Other Receivables [Member]
Accounts Payable
Accounts Payable [Member]
Accrued expense and other current liabilities.
Accrued Expenses and Other Current Liabilities
Accrued Expense And Other Current Liabilities [Member]
Lease liabilities.
Lease Liabilities
Lease Liabilities [Member]
Foreign Currency Risk [Line Items]
Foreign Currency Risk [Line Items]
Assets exposure
Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
Liability exposure
Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
Net financial position exposure
Foreign Currency Derivative Instruments Not Designated As Hedging Instruments At Fair Value Net
Percentage of depreciation USD against Canadian dollar.
Percentage of depreciation USD against Canadian dollar
Percentage Of Depreciation U S D Against Canadian Dollar
Increase in net loss currency risk
Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
Schedule Of Related Party Transactions By Related Party [Table]
Schedule Of Related Party Transactions By Related Party [Table]
Related Party Transaction
Related Party Transaction [Axis]
Related Party Transaction
Related Party Transaction [Domain]
Research services and rent paid.
Research Services and Rent Paid
Research Services And Rent Paid [Member]
Related Party
Related Party Transactions By Related Party [Axis]
Related Party
Related Party [Domain]
Affiliated Entity
Affiliated Entity [Member]
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Expenses from transactions with related party
Related Party Transaction Expenses From Transactions With Related Party
Due to related parties, current
Due To Related Parties Current
Schedule Of Segment Reporting Information By Segment [Table]
Schedule Of Segment Reporting Information By Segment [Table]
Canada
CALIFORNIA
United States
UNITED STATES
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Subsequent Event [Table]
Subsequent Event [Table]
Scenario
Statement Scenario [Axis]
Scenario
Scenario Unspecified [Domain]
Scenario Forecast
Scenario Forecast [Member]
Subsequent Event [Line Items]
Subsequent Event [Line Items]